Inova captures record 38% market share in 2015

Business development teams at 2 out of 5 Top 50 pharma companies use Inova for their centralized partnering solution, making Inova the leading solution by far

Inova’s market share grew significantly over the last year, reinforcing Inova’s position as the leading life sciences’ partnering solution. 38% of the Top 50 pharma companies now use Inova, an increase of 8 percentage points over last year. Inova’s closest competitor lags behind with just 12% market share.

Inova’s success was driven by several factors, including:

  • The life science industry’s need for a CRM dedicated to partnering
  • Inova’s strategic partnerships with BIO and Thomson Reuters, which reduce manual data entry
  • Inova’s CRM is ready out-of-the-box and can be deployed in just two days

“We’re very proud of our market leadership. It reflects the fact that Inova is dedicated to partnering in the life sciences and to developing a CRM that brings value to our clients,” said Gilles Toulemonde, Inova CEO. “We want our solution to be powerful, but intuitive and user-friendly. For example, we know that manual data entry is by far the biggest pain in using any CRM. That’s why we created connectors that bring data in from partnering events and content providers in just a few clicks. Based on current discussions with Top 100 pharma companies and many biotechs, we expect similar growth in 2016.”